Patent · US Active

Method of relieving symptoms of gastroesophageal reflux disease

US7846921B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Rottapharm SpA · IT

Inventors

Lucio Claudio Rovati · Monza, IT
Gianfranco Caselli · L'Aquila, IT
Massimo Maria D'Amato · Monza, IT
Antonio Giordani · Pavia, IT
Francesco Makovec · Monza, IT

Key dates

Filing date	Jul 24, 2006
Grant date	Dec 7, 2010
Priority date	—
Expiry date	Dec 29, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for relieving or ameliorating symptoms of gastroesophageal reflux disease by administering a medicament that includes the cholecystokin-2 (CCK-2) receptor antagonist itriglumide and a proton pump inhibitor (PPI).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.